Cargando…

Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival

Immunotherapeutic strategies for glioblastoma, the most frequent malignant primary brain tumor, aim to improve its disastrous consequences. On top of the standard treatment, one strategy uses T cell activation by autologous dendritic cells (DC) ex vivo loaded with tumor lysate to attack remaining ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belmans, Jochen, Van Woensel, Matthias, Creyns, Brecht, Dejaegher, Joost, Bullens, Dominique M., Van Gool, Stefaan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654749/ https://www.ncbi.nlm.nih.gov/pubmed/29066810 http://dx.doi.org/10.1038/s41598-017-12584-0

Ejemplares similares

Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
por: Vandenberk, Lien, et al.
Publicado: (2016)

Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response
por: Dejaegher, Joost, et al.
Publicado: (2014)

Autologous and Pooled Tumor Lysates in Combined Immunotherapy of Patients with Glioblastoma
por: Mishinov, S.V., et al.
Publicado: (2020)

Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
por: Van Woensel, Matthias, et al.
Publicado: (2017)

Novel strategy for manufacturing autologous dendritic cell/allogeneic tumor lysate vaccines for glioblastoma
por: Parney, Ian F, et al.
Publicado: (2020)

Immunotherapy of Malignant Melanoma with Tumor Lysate-Pulsed Autologous Monocyte-Derived Dendritic Cells
por: Kim, Dae Suk, et al.
Publicado: (2011)

Autologous tumor lysate/Bacillus Calmette–Guérin immunotherapy as an adjuvant to conventional breast cancer therapy
por: Convit, J., et al.
Publicado: (2015)

Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)

Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth
por: Mathivet, Thomas, et al.
Publicado: (2017)

Erratum to: Autologous tumor lysate/Bacillus Calmette–Guérin immunotherapy as an adjuvant to conventional breast cancer therapy
por: Convit, J., et al.
Publicado: (2016)

Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination
por: Pasqualetti, Francesco, et al.
Publicado: (2023)

Dendritic cell-based immunotherapy in ovarian cancer
por: Coosemans, An, et al.
Publicado: (2013)

Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells
por: Creyns, Brecht, et al.
Publicado: (2020)

The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
por: Vonk, Marlotte M., et al.
Publicado: (2017)

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
por: Schirrmacher, Volker, et al.
Publicado: (2022)

Immunocompetent murine models for the study of glioblastoma immunotherapy
por: Oh, Taemin, et al.
Publicado: (2014)

Autologous platelet lysate local injections for the treatment of refractory lateral epicondylitis
por: Tan, Xun-xiang, et al.
Publicado: (2016)

Characteristics of Platelet Lysate Compared to Autologous and Allogeneic Serum Eye Drops
por: Zhang, Jie, et al.
Publicado: (2020)

Murine subcutaneous immunotherapy models with beneficial immunological and physiological effects
por: Chang, Yoon-Seok, et al.
Publicado: (2013)

Super Activated Platelet Lysate, a Novel Autologous Platelet Lysate, Regulates the Expression of Inflammasome and Cytokine in the Experimental Periodontitis in Rats
por: Zhang, Yi, et al.
Publicado: (2020)

Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma
por: Parney, Ian F, et al.
Publicado: (2022)

Bacterial Lysates as Immunotherapies for Respiratory Infections: Methods of Preparation
por: Suárez, Norma, et al.
Publicado: (2020)

Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy with Cytokine-Induced Killer Cells Improves Survival in Gastric and Colorectal Cancer Patients
por: Gao, Daiqing, et al.
Publicado: (2014)

Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
por: Vandenberk, Lien, et al.
Publicado: (2015)

The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study
por: Fea, Antonio M., et al.
Publicado: (2016)

Human Platelet Lysate as an Alternative to Autologous Serum for Human Chondrocyte Clinical Use
por: Philippe, Virginie, et al.
Publicado: (2021)

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
por: Van Gool, Stefaan W., et al.
Publicado: (2023)

Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
por: Rojas-Sepúlveda, Daniel, et al.
Publicado: (2018)

Multidimensional, patient-reported outcome after posterior fossa decompression in 79 patients with Chiari malformation type I
por: De Vlieger, Jan, et al.
Publicado: (2019)

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
por: Pellegatta, Serena, et al.
Publicado: (2013)

Autologous Antibody Capture to Enrich Immunogenic Viruses for Viral Discovery
por: Oude Munnink, Bas B., et al.
Publicado: (2013)

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy
por: Fiammenghi, Laura, et al.
Publicado: (2010)

Prospective Study in Children with Complicated Urinary Tract Infection Treated with Autologous Bacterial Lysates
por: Hernández-Chiñas, Ulises, et al.
Publicado: (2021)

Establishment and characterization of murine models of asthma and subcutaneous immunotherapy for Humulus pollen allergy
por: Xi, Guang P., et al.
Publicado: (2021)

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
por: van Woensel, Matthias, et al.
Publicado: (2013)

Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells
por: Wenger, Anna, et al.
Publicado: (2017)

IMMU-02. CMV-EXPANDED T-CELLS IN GLIOBLASTOMA PATIENTS: TRANSLATIONAL RESEARCH
por: Kampers, Linde F C, et al.
Publicado: (2023)

Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma
por: Zhang, Lu, et al.
Publicado: (2012)

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
por: Van Gool, Stefaan W., et al.
Publicado: (2020)

Advances in immunotherapy for the treatment of glioblastoma
por: Tivnan, Amanda, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_25ulipmpgitqm01ibr6aslrl5p